« Previous
Next »
Archives of Physical Medicine and Rehabilitation
Volume 88, Issue 9
, Pages
1108-1113
, September 2007
Construct and Predictive Validity of a Self-Reported Measure of Preclinical Mobility Limitation
-
Adjusted mean differences (in percent) and their 95% CI in (A) maximal walking speed and (B) lower-extremity muscle power compared with people with preclinical mobility limitation (0 level).
Adjusted mean differences (in percent) and their 95% CI in (A) maximal walking speed and (B) lower-extremity muscle power compared with people with preclinical mobility limitation (0 level).
-
Unadjusted prevalence (in percent) of major manifest limitation for the (A) 2-km walk, (B) 0.5-km walk, and (C) climbing up 1 flight of stairs during 24-month follow-up. NOTE. At baseline, the number
Unadjusted prevalence (in percent) of major manifest limitation for the (A) 2-km walk, (B) 0.5-km walk, and (C) climbing up 1 flight of stairs during 24-month follow-up. NOTE. At baseline, the number of participants with preclinical mobility limitation in 2km was 140; in 0.5-km walk, 100; and in climbing up stairs, 178. Respectively, the numbers for participants with no limitation was 74, 166, and 59, and for participants with minor manifest limitation 52, 36, and 58.
Supported by the Ministry of Health and Social Affairs, the City of Jyväskylä, Finnish Cultural Foundation and Juho Vainio Foundation.
No commercial party having a direct financial interest in the results of the research supporting this article has or will confer a benefit upon the author(s) or upon any organization with which the author(s) is/are associated.
See commentary p 1217.
PII: S0003-9993(07)00436-4
doi: 10.1016/j.apmr.2007.06.016
© 2007 American Congress of Rehabilitation Medicine and the American Academy of Physical Medicine and Rehabilitation. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Archives of Physical Medicine and Rehabilitation
Volume 88, Issue 9
, Pages
1108-1113
, September 2007
